Neurochemical Transmission: Sites of Drug Action

When an electrical impulse arrives at the presynaptic axonal terminal, calcium ions (Ca2+) influx into the terminal, triggering exocytosis. This process releases neurotransmitters, enzymes, and other proteins into the synaptic cleft. Botulinum toxin and guanadrel inhibit this release, while latrotoxin and amphetamine accelerate it.

Agonist drugs like nicotine and methacholine activate receptors by mimicking neurotransmitters, producing desired responses. Antagonist drugs like atropine and tubocurarine block receptors, preventing neurotransmitter binding and receptor activation. Both drug types modulate neurotransmission but produce opposite effects on postsynaptic neurons.

Drugs like α-methyltyrosine inhibit neurotransmitter biosynthesis by blocking synthesis pathways. Vesamicol and reserpine prevent neurotransmitter storage in synaptic vesicles. Hemicholinium blocks precursor uptake necessary for acetylcholine synthesis. These mechanisms reduce available neurotransmitters for release into the synaptic cleft and diminish synaptic transmission.

Reuptake inhibitors like hemicholinium and cocaine block the active reuptake of neurotransmitters back into presynaptic neurons. By preventing this removal, neurotransmitters remain longer in the synaptic cleft, prolonging their interaction with postsynaptic receptors. This mechanism intensifies and extends the duration of neurotransmitter effects.

After neurotransmission, neurotransmitters are either reuptaken by presynaptic neurons or degraded by enzymes. Acetylcholinesterase degrades acetylcholine into choline and acetate, clearing it from the synapse. Norepinephrine transporter reuptakes noradrenaline into the presynaptic neuron. These processes terminate neurotransmitter action and maintain synaptic homeostasis.

Autonomic drugs target multiple sites in the neurotransmission pathway. They inhibit synthesis, block vesicle storage, prevent release, activate or block receptors, and inhibit reuptake. By modulating these specific steps, autonomic drugs alter neurotransmitter availability and receptor signaling, producing therapeutic effects on autonomic nervous system function.

Understanding neurochemical transmission sites allows pharmacologists to design drugs targeting specific steps in neurotransmission. By identifying where drugs act—synthesis, storage, release, receptor binding, or reuptake—researchers can develop treatments for neurological disorders and autonomic dysfunction. This knowledge enables precise therapeutic interventions with predictable effects.